Zura Bio
Steve Schoch currently serves as the Chief Operating Officer and Chief Financial Officer at FLYR, a team dedicated to revolutionizing the travel and transportation industry through advanced technologies. He also holds positions as a Board Member and Audit Committee Chair at Zura Bio Limited and was previously the Chief Financial Officer at companies such as 23andMe and Miramax. Steve's educational background includes a Bachelor of Science in Engineering from Tufts University and a Master of Business Administration from The Tuck School of Business at Dartmouth.
This person is not in the org chart
This person is not in any teams
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.